See All Slides - tctmd.com

Slides

Presentation TCT 2013

FDA Perspectives on HBD: Past, Present, and Future (videotape)

Presenter: Jeff Shuren

October 27, 2013

Presentation TCT 2013

Device and Clinical Trial Update: Allegro/Iberis (Angiocare/Terumo)

Presenter: Xiongjing Jiang

October 27, 2013

Presentation TCT 2013

Connecting the Disparate Dots: The Development of the TIPS Procedure

Presenter: Barry Katzen

October 27, 2013

Presentation TCT 2013

The Spectrum of Current and Future Renal Denervation Clinical Trials

Presenter: Mehdi Shishehbor

October 27, 2013

Presentation TCT 2013

Be Afraid!

Presenter: Darrel Francis

October 27, 2013

Presentation TCT 2013

LAA Closure is Now Established - The Added Value of New Randomized Trials Would be Minimal!

Presenter: Matthew Price

October 27, 2013

Presentation TCT 2013

Emerging Technologies for CLI: Advantages to Working Together

Presenter: Hiroyoshi Yokoi

October 27, 2013

Presentation TCT 2013

ReZolve Sirolimus-eluting BRS Based on an Iodinated Tyrosine Derivative: Device Iteration and Extended Imaging and Clinical Results

Presenter: Ricardo Costa

October 27, 2013

Presentation TCT 2013

Multicenter Experience with the ACP for Stroke Prevention in Atrial Fibrillation

Presenter: Apostolos Tzikas

October 27, 2013

Presentation TCT 2013

Which High-Risk AS Patients Should be Treated with TAVR and Which are Better Suited for Surgical AVR

Presenter: Neil Moat

October 27, 2013

Advertisement

Slides

FDA Perspectives on HBD: Past, Present, and Future (videotape)

Device and Clinical Trial Update: Allegro/Iberis (Angiocare/Terumo)

Connecting the Disparate Dots: The Development of the TIPS Procedure

The Spectrum of Current and Future Renal Denervation Clinical Trials

Be Afraid!

LAA Closure is Now Established - The Added Value of New Randomized Trials Would be Minimal!

Emerging Technologies for CLI: Advantages to Working Together

ReZolve Sirolimus-eluting BRS Based on an Iodinated Tyrosine Derivative: Device Iteration and Extended Imaging and Clinical Results

Multicenter Experience with the ACP for Stroke Prevention in Atrial Fibrillation

Which High-Risk AS Patients Should be Treated with TAVR and Which are Better Suited for Surgical AVR

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content